TABLE 2.

Safety and Feasibility of Multimodal Treatment Program

Parameter	n (%) or mean ± sd
Consent success
Yes, n	32 (71)
No, n	13 (29)a
Selected in-person pathway	22 (69)
Selected telehealth pathway	10 (31)
Minor adverse events	3
Major adverse events	1
Rate of adverse event occurrence per total number of sessions	4/325 (1.2)
Attrition	3 (9.4)b
Attendance to ICU Recovery Clinic appointments
Attended, mean ± sd	2.69 ± 1.10
Scheduled, mean ± sd	2.93 ± 0.95
Percent attendance	88% ± 24%
Attendance to Physical Therapy appointments
Attended, mean ± sd	10.2 ± 4.7
Scheduled, mean ± sd	12.7 ± 3.4
Percent attendance	78.4% ± 26%
Frequency per wk	1.34 ± 0.5
Adherence to home-exercise plan
Days completed, mean ± sd	2.48 ± 1.1
Percent completed of prescribed	65% ± 28%
Adherence to walking/aerobic program
Days completed, mean ± sd	4.34 ± 1.6
Percent completed of daily walking	62% ± 23%

^aThirteen patients refused or deferred need to participate: five patients were already participating in home-based or outpatient physical therapy, four patients had returned to work or prehospital function and deferred the need for treatment, two patients were not interested in research, and two patients did not provide a reason.

^bThree patients did not complete the study: one readmitted and did not reenter study posthospital discharge; eventually, the patient required a second readmission and expired due to acute or chronic respiratory failure with history of chronic obstructive pulmonary disease (in-person), one patient readmitted to hospital for pneumothorax and did not reenter study (in-person), and one patient asked to be removed due to personal reasons (telehealth).